Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Phillips, Robert S ^a   Lehrnbecher, Thomas ^b   Alexander, Sarah ^c   Sung, Lillian ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b GOETHE UNIVERSITY   (Germany)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; CANCER PATIENT; CHILD; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DATA BASE; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; DRUG MEGADOSE; FEBRILE NEUTROPENIA; GEOGRAPHY; HUMAN; META ANALYSIS; PATIENT INFORMATION; PRACTICE GUIDELINE; PREDICTION; PROSPECTIVE STUDY; PUBLICATION; RELIABILITY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VALIDATION PROCESS; DECISION MAKING; FEVER; METHODOLOGY; NEOPLASM; NEUTROPENIA; QUALITY CONTROL; STANDARD;

CHILD; DECISION MAKING; FEVER; HUMANS; NEOPLASMS; NEUTROPENIA; QUALITY CONTROL; RISK ASSESSMENT;

EID: 84861714054     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038300     Document Type: Review

References (32)

1. Phillips B, Selwood K, Lane SM, Skinner R, Gibson F, et al. (2007) Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child 92: 495-498.
2. Dommett R, Geary J, Freeman S, Hartley J, Sharland M, et al. (2009) Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting. EJC 45: 2843-2849.
3. Phillips B, Wade R, Stewart LA, Sutton AJ, (2010) Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. EJC 46: 2950-2964.
4. Teuffel O, Ethier MC, Alibhai SM, Beyene J, Sung L, (2011) Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol 22: 2358-2365.
5. Freifeld AG, Sepkowitz KA, (2011) No place like home? Outpatient management of patients with febrile neutropenia and low risk. J Clin Oncol 29: 3952-3954.
6. Sung L, Phillips R, Lehrnbecher T, (2011) Time for paediatric febrile neutropenia guidelines - Children are not little adults. EJC 47: 811-813.
7. Ammann RA, Bodmer N, Hirt A, Niggli FK, Nadal D, et al. (2010) Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 28: 2008-2014.
8. Centre for Reviews and Dissemination (2009) Systematic review: CRD's guidance for undertaking reviews in health care. York University of York.
9. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, et al. (1999) Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282: 1061-1066.
10. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 3: 25-25.
11. Simel DL, Bossuyt PM, (2009) Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. J Clin Epidemiol 62: 1292-1300.
12. Harbord R, (2008) METANDI: Stata module to perform meta-analysis of diagnostic accuracy. S456932 ed Department of Social Medicine, University of Bristol.
13. Lunn D, Thomas A, Best N, Spiegelhalter D, (2000) WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics and Computing 10: 337, 325-337, 325.
14. Delebarre M, Dubos F, Macher E, Garnier N, Mazingue F, et al. (2010) Identifying high-risk patients for severe infection in children with chemotherapy-induced febrile neutropenia: A new decision rule. Pediatr Blood Cancer 55: 823.
15. Mian A, Prodhan P, Bhutta A, Watkins B, (2009) Clinical variables and acute phase reactants at initial hospitalization as predictors of admission to intensive care unit (ICU) among febrile neutropenic children. Crit Care Med 37: A344.
16. Hakim H, Flynn PM, Srivastava DK, Knapp KM, Li C, et al. (2010) Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J 29: 53-59.
17. Badiei Z, Khalesi M, Alami MH, Kianifar HR, Banihashem A, et al. (2011) Risk factors associated with life-threatening infections in children with febrile neutropenia: a data mining approach. J Pediatr Hematol Oncol 33: e9-e12.
18. Agyeman P, Aebi C, Hirt A, Niggli FK, Nadal D, et al. (2011) Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J 30: e114-119.
19. Miedema KG, de Bont ES, Oude Nijhuis CS, van Vliet D, Kamps WA, et al. (2011) Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. J Clin Oncol 29: e182-184; author reply e185.
20. Macher E, Dubos F, Garnier N, Delebarre M, De Berranger E, et al. (2010) Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatr Blood Cancer 55: 662-667.
21. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB, (1996) Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol 14: 919-924.
22. Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR, (2001) Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 92: 909-913.
23. Madsen K, Rosenman M, Hui S, Breitfeld PP, (2002) Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol 24: 256-262.
24. Klaassen RJ, Goodman TR, Pham B, Doyle JJ, (2000) "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 18: 1012-1019.
25. Santolaya ME, Alvarez AM, Avil's CL, Becker A, Cofr' J, et al. (2002) Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clinical Infectious Diseases 35: 678-683.
26. Santolaya ME, Alvarez AM, Becker A, Cofre J, Enriquez N, et al. (2001) Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19: 3415-3421.
27. Rondinelli PIP, Ribeiro KdCB, de Camargo B, (2006) A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol 28: 665-670.
28. Alexander SW, Wade KC, Hibberd PL, Parsons SK, (2002) Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 24: 38-42.
29. Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y, (2008) Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 61: 76-86.
30. Toll DB, Janssen KJM, Vergouwe Y, Moons KGM, (2008) Validation, updating and impact of clinical prediction rules: A review. J Clin Epidemiol 61: 1085-1094.
31. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873.
32. Ammann RA, Hirt A, Luthy AR, Aebi C, (2003) Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Medical & Pediatric Oncology 41: 436-443.